Peptide Antibiotics Market Overview
Peptide antibiotics belong to the class of anti-infective and antitumor antibiotic containing polypeptide chains. These peptide antibiotics usually fall into two categories ribosomal synthesized and non-ribosomal synthesized peptide antibiotics. Due to various benefits of peptide antibiotics such as high efficacy, high specificity, low toxicity, etc. the peptide antibiotics are highly in demand.
Also, due to rising cases of antibiotic resistance creating a threat for the manufacturer, the peptide antibiotics were taken into account to overcome the above issue. The intensive research and development activities in the field of peptide antibiotics are likely to create more scopes and opportunities for the market players over the forecast period.
Peptide Antibiotics Market: Drivers and Restraints
Increasing demand for peptide antibiotics in hospitals and clinics is the major factor driving the growth of the peptide antibiotics market. The intensive research and development activities in the field of peptide antibiotics are further anticipated to support growth of the peptide antibiotics market.
The market players are heavily investing in the research and development activities to expand the applications of peptide antibiotics. Also, the growing competition among the market players and rapid upsurge in the number of manufacturers are further expected to aid in the growth of the peptide antibiotics market.
Also, the increasing FDA approval of peptide antibiotics drugs and stringent reimbursement policy is boosting the growth of the peptide antibiotics market. Recent advancement and innovation in the field of peptide antibiotics are creating a favourable scenario for peptide antibiotics market. However, there are many side effects associated with the long term use of the peptide antibiotics, which in turn is hampering the growth of the peptide antibiotics market.
Peptide Antibiotics Market: Overview
The peptide antibiotics market is projected to witness prominent growth during the forecast period. On the basis of product type, the peptide antibiotics market is categorized into ribosomal synthesized peptide antibiotics and non-ribosomal synthesized peptide antibiotics.
Among the product type, non-ribosomal synthesized peptide antibiotics segment is expected to dominate the peptide antibiotics market, owing to the increasing demand and availability of these peptide antibiotics. Among the route of administration, the oral segment is expected to dominate the peptide antibiotics market.
Based on the distribution channel, retail pharmacy is accounted to have a significant market share in the peptide antibiotics market due to higher patient footfall.
Peptide Antibiotics Market: Regional Wise Outlook
The Peptide antibiotics market is anticipated to experience robust growth in the near future. North America is accounted to have a significant market share in terms of revenue and is expected to dominate the peptide antibiotics market over the forecast period.
This is attributed to the presence of market players in the region and increasing demand for antibiotics in the region. Also, the increasing R & D activities in the region are further anticipated to surge the peptide antibiotics market growth in the region.
Europe is expected to be the second most lucrative region, owing to the higher adoption of peptide antibiotics in the region. Also, improvement in healthcare infrastructure facility and FDA approval of peptide antibiotics is further anticipated to boost the growth of the peptide antibiotics market in the region.
The Asia Pacific is projected to witness significant growth over the forecast period. This is due to the rising awareness of people towards their health and increasing disposable income in developing countries like India, China, etc. Latin America is subjected to register stable growth in the peptide antibiotics market.
Peptide Antibiotics Market: Key Players
The Key players operating in peptide antibiotics market are Novartis, Eli Lilly & co., GlaxoSmithKline Plc., Pfizer, Theravance Biopharma, Vicuron Pharmaceuticals, AMP Therapeutics, Savara Pharmaceuticals, Pacgen Life Science Corporation, and Kasten
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology Matrix
- Value Chain
Regional analysis of the Peptide Antibiotics Market report includes
- North America
- Latin America
- South Asia
- East Asia
- Middle East and Africa
Peptide Antibiotics Market: Segmentation
The peptide antibiotics market is segmented based on product type, route of administration, and distribution channel.
Based on Product Type, the global Peptide Antibiotics Market is segmented as:
- Ribosomal Synthesized Peptide Antibiotics
- Non-ribosomal Synthesized Peptide Antibiotics
Based on the route of administration, the global Peptide Antibiotics Market is segmented as:
Based on the distribution channel, the global Peptide Antibiotics Market is segmented as:
- Retail Pharmacy
- Drug Stores